These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6141471)

  • 21. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.
    Campieri M; Lanfranchi GA; Bazzocchi G; Brignola C; Sarti F; Franzin G; Battocchia A; Labo G; Dal Monte PR
    Lancet; 1981 Aug; 2(8241):270-1. PubMed ID: 6114321
    [No Abstract]   [Full Text] [Related]  

  • 22. Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis.
    d'Albasio G; Trallori G; Ghetti A; Milla M; Nucci A; Pacini F; Morettini A
    Dis Colon Rectum; 1990 May; 33(5):394-7. PubMed ID: 1970284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulfasalazine and new analogues.
    Friedman G
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract]   [Full Text] [Related]  

  • 24. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL
    Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Aminosalicylic acid enemas in distal colitis.
    Rao SS
    Gastroenterology; 1988 Dec; 95(6):1698-9. PubMed ID: 3181693
    [No Abstract]   [Full Text] [Related]  

  • 26. Retrograde spread of mesalazine (5-aminosalicylic acid)-containing enema in patients with ulcerative colitis.
    Tiel-van Buul MM; Mulder CJ; van Royen EA; Wiltink EH; Tytgat GN
    Clin Pharmacokinet; 1991 Mar; 20(3):247-51. PubMed ID: 2025983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rowasa suspension enema (mesalamine, USP).
    Ciarleglio CA
    Gastroenterol Nurs; 1989; 12(2):122-4. PubMed ID: 2487824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mesalazine enema for ulcerative colitis.
    Drug Ther Bull; 1994 May; 32(5):38-9. PubMed ID: 7635028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatitis after rectal administration of 5-aminosalicylic acid.
    Isaacs KL; Murphy D
    J Clin Gastroenterol; 1990 Apr; 12(2):198-9. PubMed ID: 1969872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term use of mesalamine enemas to induce remission in ulcerative colitis.
    Biddle WL; Miner PB
    Gastroenterology; 1990 Jul; 99(1):113-8. PubMed ID: 1971605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis.
    Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
    Gastroenterology; 1988 Jun; 94(6):1383-9. PubMed ID: 2896139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of rectal formulations: enemas.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Petronelli A; Miglioli M; Barbara L
    Scand J Gastroenterol Suppl; 1990; 172():63-5. PubMed ID: 2353173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of hemorrhagic rectocolitis with 5-aminosalicylic acid enema].
    Benedittini N; Farinotti R; Rene E; Likforman J; Dauphin A; Mignon M
    Presse Med; 1985 Mar; 14(13):748. PubMed ID: 3157983
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversal of male infertility on changing treatment from sulphasalazine to 5-aminosalicylic acid.
    Cann PA; Holdsworth CD
    Lancet; 1984 May; 1(8386):1119. PubMed ID: 6144844
    [No Abstract]   [Full Text] [Related]  

  • 36. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage].
    Bresci G; Carrai M; Venturini G; Gambardella L
    Minerva Dietol Gastroenterol; 1990; 36(1):31-3. PubMed ID: 1970855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis?
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tabanelli GM; Miglioli M; Barbara L
    J Clin Gastroenterol; 1988 Aug; 10(4):406-9. PubMed ID: 3418088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [5-aminosalicylic acid treatment of ulcerative colitis during the acute phase in patients resistant or intolerant to salazopyrine].
    Cappello M; Puleo A; Calabrese A; Cipolla C; Orlando A; Gatto G; Oliva L; Cottone M
    Recenti Prog Med; 1987 Feb; 78(2):76-8. PubMed ID: 2884701
    [No Abstract]   [Full Text] [Related]  

  • 39. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine.
    Donald IP; Wilkinson SP
    Postgrad Med J; 1985 Dec; 61(722):1047-8. PubMed ID: 2869480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
    Rutgeerts P
    Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.